These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35269932)

  • 1. Molecular Research in Multiple Sclerosis.
    Fucito M; Pieragostino D
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA in multiple sclerosis: search for novel biomarkers.
    Gandhi R
    Mult Scler; 2015 Aug; 21(9):1095-103. PubMed ID: 25921051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood biomarkers in multiple sclerosis.
    D'Ambrosio A; Pontecorvo S; Colasanti T; Zamboni S; Francia A; Margutti P
    Autoimmun Rev; 2015 Dec; 14(12):1097-110. PubMed ID: 26226413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: genetics, biomarkers, treatments.
    Axisa PP; Hafler DA
    Curr Opin Neurol; 2016 Jun; 29(3):345-53. PubMed ID: 27058221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.
    Pravica V; Popadic D; Savic E; Markovic M; Drulovic J; Mostarica-Stojkovic M
    Immunol Res; 2012 Apr; 52(1-2):42-52. PubMed ID: 22392049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances of long noncoding RNAs involved in the development of multiple sclerosis.
    Li QW; Lei W; Chen C; Guo W
    Chin J Nat Med; 2020 Jan; 18(1):36-46. PubMed ID: 31955822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: from molecules to treatment.
    Broadley SA
    Int J Mol Sci; 2013 Apr; 14(4):7598-602. PubMed ID: 23612323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmatic microRNA as Potential Biomarkers of Multiple Sclerosis: Literature Review.
    Kacperska MJ; Walenczak J; Tomasik B
    Adv Clin Exp Med; 2016; 25(4):775-9. PubMed ID: 27629854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.
    Piket E; Zheleznyakova GY; Kular L; Jagodic M
    J Autoimmun; 2019 Jul; 101():17-25. PubMed ID: 31014917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
    Tossberg JT; Crooke PS; Henderson MA; Sriram S; Mrelashvili D; Chitnis S; Polman C; Vosslamber S; Verweij CL; Olsen NJ; Aune TM
    Genes Immun; 2012 Feb; 13(2):146-54. PubMed ID: 21938015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic research in multiple sclerosis: progress, challenges, and opportunities.
    Zheleznyakova GY; Piket E; Marabita F; Pahlevan Kakhki M; Ewing E; Ruhrmann S; Needhamsen M; Jagodic M; Kular L
    Physiol Genomics; 2017 Sep; 49(9):447-461. PubMed ID: 28754822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in multiple sclerosis.
    Housley WJ; Pitt D; Hafler DA
    Clin Immunol; 2015 Nov; 161(1):51-8. PubMed ID: 26143623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics for understanding and predicting clinical progression in multiple sclerosis.
    Depaz R; Granger B; Cournu-Rebeix I; Bouafia A; Fontaine B
    Rev Neurol (Paris); 2011 Nov; 167(11):791-801. PubMed ID: 21683424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?].
    Fontaine B
    Rev Neurol (Paris); 2012 Nov; 168(11):833-5. PubMed ID: 22959703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of OIP5-AS1/HUR1 to discover new potential biomarkers and therapeutic targets in multiple sclerosis.
    Gharesouran J; Taheri M; Sayad A; Mazdeh M; Omrani MD
    J Cell Physiol; 2019 Aug; 234(10):17351-17360. PubMed ID: 30815864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum proteomics in multiple sclerosis disease progression.
    Tremlett H; Dai DL; Hollander Z; Kapanen A; Aziz T; Wilson-McManus JE; Tebbutt SJ; Borchers CH; Oger J; Cohen Freue GV
    J Proteomics; 2015 Apr; 118():2-11. PubMed ID: 25753122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics-based technologies in the discovery of biomarkers for multiple sclerosis in the cerebrospinal fluid.
    Lourenço AS; Baldeiras I; Grãos M; Duarte CB
    Curr Mol Med; 2011 Jun; 11(4):326-49. PubMed ID: 21506919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
    Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
    Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-interferon for multiple sclerosis.
    Rudick RA; Goelz SE
    Exp Cell Res; 2011 May; 317(9):1301-11. PubMed ID: 21396360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic aspects in multiple sclerosis. II: HLA system].
    De Rezende PA; Arruda WO
    Arq Neuropsiquiatr; 1996 Sep; 54(3):439-50. PubMed ID: 9109989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.